These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 35032406)

  • 1. PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery.
    Sheffey VV; Siew EB; Tanner EEL; Eniola-Adefeso O
    Adv Healthc Mater; 2022 Apr; 11(8):e2101536. PubMed ID: 35032406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
    Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
    J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview.
    Kumar L; Kukreti G; Rana R; Chaurasia H; Sharma A; Sharma N; Komal
    Curr Pharm Des; 2023; 29(37):2940-2953. PubMed ID: 38173050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles Based on Novel Carbohydrate-Functionalized Polymers.
    Raposo CD; Conceição CA; Barros MT
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the drug encapsulation of poly(lactic-
    Dodda JM; Remiš T; Rotimi S; Yeh YC
    J Mater Chem B; 2022 Jun; 10(22):4127-4141. PubMed ID: 35593381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S; Sahoo SK
    Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery.
    Amoozgar Z; Park J; Lin Q; Yeo Y
    Mol Pharm; 2012 May; 9(5):1262-70. PubMed ID: 22489704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin.
    Samkange T; D'Souza S; Obikeze K; Dube A
    J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.
    Gullotti E; Park J; Yeo Y
    Pharm Res; 2013 Aug; 30(8):1956-67. PubMed ID: 23609560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable self-assembled nanoparticles of PEG-PLGA amphiphilic diblock copolymer as a promising stealth system for augmented vinpocetine brain delivery.
    Ahmed OAA; Badr-Eldin SM
    Int J Pharm; 2020 Oct; 588():119778. PubMed ID: 32805381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic Manufacturing of Multitargeted PLGA/PEG Nanoparticles for Delivery of Taxane Chemotherapeutics.
    Martins C; Sarmento B
    Methods Mol Biol; 2020; 2059():213-224. PubMed ID: 31435924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
    Bhattacharya S
    Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
    Avgoustakis K
    Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers.
    Chen W; Hu S
    Int J Nanomedicine; 2011; 6():1535-41. PubMed ID: 21845043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.
    Cu Y; Saltzman WM
    Mol Pharm; 2009; 6(1):173-81. PubMed ID: 19053536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.